Real-life impact of the immunological tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
Journal of the American Academy of Dermatology | Jan 27, 2022
Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis
Journal of the European Academy of Dermatology and Venereology | Dec 16, 2021